Appropriateness of medication selection for older persons in an urban academic emergency department

Academic Emergency Medicine

Volumn 6, Issue 12, 1999, Pages 1232-1241

  Chin, Marshall H ^a   Wang, Linda C ^a,b   Jin, Lei ^a   Mulliken, Robert ^a   Walter, James ^a   Hayley, Deon Cox ^a   Karrison, Theodore G ^a   Nerney, Michael P ^a,c   Miller, Annette ^a   Friedmann, Peter D ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Aging; Drugs; Emergency services; Outcomes; Pharmacology; Quality of care.

Indexed keywords

CYCLOBENZAPRINE; DIPHENHYDRAMINE; INDOMETACIN; PETHIDINE;

AGED; ARTICLE; DRUG UTILIZATION; ELDERLY CARE; EMERGENCY MEDICINE; EMERGENCY WARD; FEMALE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 17144439946     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1999.tb00139.x     Document Type: Article

References (55)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200-5.
2. Nolan L, O'Malley K. Prescribing for the elderly. Part 1: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988; 36:142-9.
3. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277: 301-6.
4. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
5. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155: 1949-56.
6. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
7. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q. 1989; 67:268-317.
8. Chutka DS, Evans JM, Fleming KC, Mikkelson KG. Drug prescribing for elderly patients. Mayo Clin Proc. 1995; 70:685-93.
9. Beers MH, Ouslander JG. Risk factors in geriatric drug prescribing: a practical guide to avoiding problems. Drugs. 1989; 37:105-12.
10. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997; 45:945-8.
11. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992; 117:634-40.
12. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991; 151:1825-32.
13. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992; 117:684-9.
14. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health. 1997; 87:404-9.
15. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994; 272:292-6.
16. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med. 1994; 154:2195-200.
17. Futterman R, Fillit H, Roglieri JL. Use of ineffective or unsafe medications among members of a Medicare HMO compared to individuals in a Medicare fee-for-service program. Am J Man Care. 1997; 3:569-75.
18. Schmader KE, Hanlon JT, Landsman P, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother. 1997; 31:529-33.
19. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992; 21:294-300.
20. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997; 157:1531-6.
21. Gurwitz JH. Suboptimal medication use in the elderly: the tip of the iceberg. JAMA. 1994; 272:316-7.
22. Sanders AB. Care of the elderly in emergency departments: conclusions and recommendations. Ann Emerg Med. 1992; 21:830-4.
23. Sanders AB (ed). Emergency Care of the Elder Person. St. Louis, MO: Beverly Cracom Publications, 1996.
24. Chin MH, Jin L, Karrison TG, et al. Older patients' health-related quality of life around an episode of emergency illness. Ann Emerg Med. 1999; 34:595-603.
25. Roccaforte WH, Burke WJ, Bayer BL, Wengel SP. Validation of a telephone version of the Mini-Mental State Examination. J Am Geriatr Soc. 1992; 40:697-702.
26. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963; 185:914-9.
27. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care. 1992; 30:473-83.
28. Baker DW, Stevens CD, Brook RH. Patients who leave a public hospital emergency department without being seen by a physician: causes and consequences. JAMA. 1991; 266:1085-90.
29. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457-81.
30. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part 2. Analysis and examples. Br J Cancer. 1977; 35:1-39.
31. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972; 34:187-220.
32. Kay R. Proportional hazard regression models and the analysis of censored survival data. Appl Stat. 1977; 26:227-37.
33. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982; 69:239-41.
34. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42:121-30.
35. Ware JE Jr, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales, Second Edition. Boston, MA: The Health Institute, New England Medical Center, 1995, p 51.
36. Hanlon JT, Schmader K, Samsa G, et al. Method for assessing the appropriateness of drug therapy. J Clin Epidemiol. 1992; 45:1045-51.
37. Schmader K, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc. 1994; 42:1241-7.
38. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing: a randomized controlled trial. Med Care. 1992; 30:646-58.
39. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA. 1998; 279:1877-82.
40. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996; 14:447-50.
41. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room: an issue in the quality of care. Ann Intern Med. 1990; 112:61-4.
42. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992; 21:1331-6.
43. Karas S Jr. The potential for drug interactions. Ann Emerg Med. 1981; 10:627-30.
44. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997; 12:523-30.
45. Brook RH, Kamberg CJ, Mayer-Oakes A, Beers MH, Raube K, Steiner A. Appropriateness of acute medical care for the elderly: an analysis of the literature. Health Policy. 1990; 14:225-42.
46. Buetow SA, Sibbald B, Cantrill JA, Halliwell S. Appropriateness in health care: application to prescribing. Soc Sci Med. 1997; 45:261-71.
47. Naylor CD. What is appropriate care? N Engl J Med. 1998; 338:1918-20.
48. Miller AE Jr. Mismedicating the elderly - says who? J Fam Pract. 1995; 41:331-6.
49. Hoehn JB, Krinksy D, Beary JF, et al. Inappropriate drug prescribing [letters]. JAMA. 1995; 273:455-7.
50. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995; 345:840-2.
51. Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA. 1990; 264:1969-73.
52. Schiff GD, Rucker TD. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA. 1998; 279:1024-9.
53. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992; 327:168-73.
54. Hamdy RC, Moore SW, Whalen K, et al. Reducing polypharmacy in extended care. South Med J. 1995; 88:534-8.
55. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996; 100:428-37.